Vaccine Information Statements (VIS) are information sheets produced by the Centers for Disease Control and Prevention (CDC) that explain to vaccine recipients, their parents, or their legal representatives both the benefits and risks of a vaccine.
Under the
National Childhood Vaccine Injury Act (NCVIA), federal law requires that VIS be handed out whenever certain vaccinations are given.
Instructions for the use of VIS and record-keeping can be viewed on the Centers for Disease Control & Prevention website. Providers should review current CDC
requirements for record-keeping. An optional consent form template is provided
as an addendum to each VIS below.
For all questions pertaining to the literature list or order form, please call Immunizations Unit at (800) 252-9152.
Table of Contents
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z |
Diphtheria, Tetanus, & Pertussis (DTP, DTaP, DT)
Vaccine Information Statements and Addendums Relating to the Diphtheria, Tetanus, & Pertussis (DTP, DTaP, DT) vaccines
Stock Number |
Title |
Revision |
EC-91 |
Diphtheria, Tetanus, & Pertussis (DTP, DTaP, DT) VIS - English (PDF)
|
08/2018 |
EC-91-add |
Diphtheria, Tetanus, & Pertussis (DTP, DTaP, DT) VIS Addendum - English (PDF)
|
08/2018 |
EC-91A |
Diphtheria, Tetanus, & Pertussis (DTP, DTaP, DT) VIS - Spanish (PDF)
|
08/2018 |
EC-91A-sup |
Diphtheria, Tetanus, & Pertussis (DTP, DTaP, DT) VIS Addendum - Spanish (PDF)
|
07/2017 |
Haemophilus influenzae Type B (Hib)
Human Papillomavirus Vaccine (HPV)
Influenza, Inactivated or Recombinant
Influenza, Live, Intranasal
Japanese Encephalitis (IXIARO)
Measles, Mumps, & Rubella (MMR)
Vaccine Information Statements and Addendums Relating to the Measles, Mumps, & Rubella (MMR) vaccine
Stock Number |
Title |
Revision |
EC-92 |
Measles, Mumps, & Rubella (MMR) VIS - English (PDF)
|
Interim 08/15/2019
|
EC-92-add |
Measles, Mumps, & Rubella (MMR) VIS Addendum - English (PDF)
|
08/2019 |
EC-92A |
Measles, Mumps, & Rubella (MMR) VIS - Spanish (PDF)
|
02/2018 |
EC-92A-sup |
Measles, Mumps, & Rubella (MMR) VIS Addendum - Spanish (PDF)
|
02/2018
|
Measles, Mumps, Rubella, & Varicella (MMRV)
Vaccine Information Statements and Addendums Relating to the Measles, Mumps, Rubella, & Varicella (MMRV) vaccine
Stock Number |
Title |
Revision |
EC-115 |
Measles, Mumps, Rubella, & Varicella (MMRV) VIS - English (PDF)
|
Interim 08/15/2019
|
EC-115-add |
Measles, Mumps, Rubella, & Varicella (MMRV) VIS Addendum - English (PDF)
|
08/2019 |
EC-115A |
Measles, Mumps, Rubella, & Varicella (MMRV) VIS - Spanish (PDF)
|
02/2018 |
EC-115A-sup |
Measles, Mumps, Rubella, & Varicella (MMRV) VIS Addendum - Spanish (PDF)
|
02/2018 |
Meningococcal, Serogroup B (MenB)
Multiple Vaccines (DTaP, Hib, Hepatitis B, Polio, and PCV13)
Pneumococcal Conjugate (PCV13)
Pneumococcal Polysaccharide (PPSV 23)
Recombinant Zoster (Shingles)
Live Zoster (Shingles)
Tetanus, Diphtheria, Pertussis (Tdap)
Vaccine Information Statements and Addendums Relating to the Tetanus, Diphtheria, and Pertussis (Tdap) vaccine
Stock Number |
Title |
Revision |
EC-109 |
Tetanus, Diphtheria, Pertussis (Tdap) VIS - English (PDF)
|
02/2015 |
EC-109-add |
Tetanus, Diphtheria, Pertussis (Tdap) VIS Addendum - English (PDF)
|
07/2017 |
EC-109A |
Tetanus, Diphtheria, Pertussis (Tdap) VIS - Spanish (PDF)
|
02/2015 |
EC-109A-sup |
Tetanus, Diphtheria, Pertussis (Tdap) VIS Addendum - Spanish (PDF)
|
07/2017 |